Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio

Author's Avatar
Aug 11, 2022

%3Cb%3ELucid+Diagnostics+Inc.%3C%2Fb%3E (Nasdaq: LUCD) (“Lucid”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of %3Cb%3EPAVmed+Inc.%3C%2Fb%3E (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced that its subsidiary, LucidDx Labs Inc. (“LucidDx Labs”), has launched four new Lucid Test Centers in Orange County, California, the Dallas-Fort Worth, Texas metropolitan area, Palm Beach County, Florida and Columbus, Ohio.